THYROXINE EMIA— 510(k) K840241

Substantially Equivalent

Collaborative Research, Inc.

FDA 510(k) clearance K840241 for THYROXINE EMIA, Substantially Equivalent on 1984-03-30. Applicant: Collaborative Research, Inc.. Device class: 2.

Clearance details

Applicant: Collaborative Research, Inc.
Product code: Code KLI
Device class: Class 2
Regulation: 21 CFR 862.1700
Advisory panel: Clinical Chemistry
Date received: 1984-01-20
Decision date: 1984-03-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLI

K160495 — VITROS® Automation Solutions2016-10-18
K131515 — ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT2013-08-14
K103484 — GSP NEONATAL THYROXINE (T4)2011-04-22
K082638 — ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL2009-02-26
K030860 — ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-3002003-08-22

More clearances from Collaborative Research, Inc.

K841541 — SERUM COMPLEMENT ACTIVITY TEST-SCAT1984-06-01

Data sourced from openFDA. This site is unofficial and independent of the FDA.